Fischetti VA - Search Results

1

Group A streptococcal vaccines: paving a path for accelerated development.

Dale JB, Fischetti VA, Carapetis JR, Steer AC, Sow S, Kumar R, Mayosi BM, Rubin FA, Mulholland K, Hombach JM, Schödel F, Henao-Restrepo AM. Dale JB, et al. Among authors: fischetti va. Vaccine. 2013 Apr 18;31 Suppl 2:B216-22. doi: 10.1016/j.vaccine.2012.09.045. Vaccine. 2013. PMID: 23598485 Review.

2

One More Disguise in the Stealth Behavior of Streptococcus pyogenes.

Fischetti VA, Dale JB. Fischetti VA, et al. mBio. 2016 May 17;7(3):e00661-16. doi: 10.1128/mBio.00661-16. mBio. 2016. PMID: 27190219 Free PMC article.

3

Group A and group B streptococcal vaccine development. A round table presentation.

Dale JB, Cleary PP, Fischetti VA, Kasper DL, Musser JM, Zabriskie JB. Dale JB, et al. Among authors: fischetti va. Adv Exp Med Biol. 1997;418:863-8. doi: 10.1007/978-1-4899-1825-3_205. Adv Exp Med Biol. 1997. PMID: 9331789

4

emm typing and validation of provisional M types for group A streptococci.

Facklam R, Beall B, Efstratiou A, Fischetti V, Johnson D, Kaplan E, Kriz P, Lovgren M, Martin D, Schwartz B, Totolian A, Bessen D, Hollingshead S, Rubin F, Scott J, Tyrrell G. Facklam R, et al. Emerg Infect Dis. 1999 Mar-Apr;5(2):247-53. doi: 10.3201/eid0502.990209. Emerg Infect Dis. 1999. PMID: 10221877 Free PMC article.

5

Vaccine Approaches To Protect against Group A Streptococcal Pharyngitis.

Fischetti VA. Fischetti VA. Microbiol Spectr. 2019 May;7(3). doi: 10.1128/microbiolspec.GPP3-0010-2018. Microbiol Spectr. 2019. PMID: 31111819 Free article. Review.

6

Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients.

Bessen DE, Veasy LG, Hill HR, Augustine NH, Fischetti VA. Bessen DE, et al. Among authors: fischetti va. J Infect Dis. 1995 Dec;172(6):1608-11. doi: 10.1093/infdis/172.6.1608. J Infect Dis. 1995. PMID: 7594728

7

Protection against streptococcal pharyngeal colonization with a vaccinia: M protein recombinant.

Fischetti VA, Hodges WM, Hruby DE. Fischetti VA, et al. Science. 1989 Jun 23;244(4911):1487-90. doi: 10.1126/science.2660266. Science. 1989. PMID: 2660266

8

Clinical and microbiological responses of volunteers to combined intranasal and oral inoculation with a Streptococcus gordonii carrier strain intended for future use as a group A streptococcus vaccine.

Kotloff KL, Wasserman SS, Jones KF, Livio S, Hruby DE, Franke CA, Fischetti VA. Kotloff KL, et al. Among authors: fischetti va. Infect Immun. 2005 Apr;73(4):2360-6. doi: 10.1128/IAI.73.4.2360-2366.2005. Infect Immun. 2005. PMID: 15784582 Free PMC article. Clinical Trial.

9

Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study.

Jones KF, Whitehead SS, Cunningham MW, Fischetti VA. Jones KF, et al. Among authors: fischetti va. Infect Immun. 2000 Dec;68(12):7132-6. doi: 10.1128/IAI.68.12.7132-7136.2000. Infect Immun. 2000. PMID: 11083840 Free PMC article.

10

Streptococcal M protein.

Fischetti VA. Fischetti VA. Sci Am. 1991 Jun;264(6):58-65. doi: 10.1038/scientificamerican0691-58. Sci Am. 1991. PMID: 1857955 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

313 results

Search Page